Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API


AIM ImmunoTech Announces IRB Approval To Enroll COVID-19 'Long Haulers' In AMP-511 ME/CFS Clinical Trial Of Ampligen


RTTNews | Oct 6, 2020 09:06AM EDT

09:05 Tuesday, October 6, 2020 (RTTNews) - AIM ImmunoTech Announces IRB Approval To Enroll COVID-19 'Long Haulers' In AMP-511 ME/CFS Clinical Trial Of Ampligen

For comments and feedback: contact editorial@rttnews.comCopyright(c) 2020 RTTNews.com. All Rights Reserved






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-5
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC